How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].

Bibliographic Details
Main Authors: Anna Falanga, Hugo Ten Cate, Bianca Rocca
Format: Article
Language:English
Published: PAGEPress Publications 2023-01-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://btvb.org/btvb/article/view/60